Dynamic analysis of hepatitis B virus DNA and its antigens in 2.2.15 cells

被引:13
作者
Liu, MC [1 ]
Yu, M [1 ]
Zhang, NL [1 ]
Gong, WB [1 ]
Wang, Y [1 ]
Piao, WH [1 ]
Wang, QH [1 ]
Wang, GQ [1 ]
机构
[1] Peking Univ, Hosp 1, Dept Infect Dis, Beijing 100034, Peoples R China
关键词
correlation; covalently closed circular DNA; hepatitis B virus antigen; hepatitis B virus DNA;
D O I
10.1046/j.1365-2893.2003.00485.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The 2.2.15 cells-derived from HepG2 cells transfected with a plasmid containing hepatitis B virus (HBV) DNA secrete surface antigen (HBsAg) particles, nucleocapsids and virions (Proc Natl Acad Sci U S A 1987; 84: 1005-1009). The latter elicit acute hepatitis in chimpanzees (Proc Natl Acad Sci U S A 1987; 84: 4641-4644). We studied the presence of intracellular and extracellular HBV covalently closed circular (ccc) DNA in this culture system by polymerase chain reaction (PCR), kinetically analysed HBsAg and hepatitis B e antigen (HBeAg) released in the culture media by quantitative enzyme-linked immunosorbent assay and quantitated by real-time PCR but HBV DNA from intracellular and extracellular HBV-DNA. HBV cccDNA was found both intracellularly and extracellularly. A significant correlation was seen between the extracellular HBV DNA levels and virus antigens (r = 0.833; P = 0.01 and r = 0.939; P < 0.01 for HBsAg and HBeAg, respectively), whereas there was no statistical correlation between intracellular HBV DNA levels and virus antigen levels (r = 0.024; P = 0.955 and r = 0.177; P = 0.625 for HBsAg and HBeAg, respectively). These data would be valuable in studies of the HBV life cycle and of potential anti-viral agents.
引用
收藏
页码:124 / 129
页数:6
相关论文
共 28 条
[1]  
Acs G, 1990, Prog Liver Dis, V9, P379
[2]   HEPATITIS-B VIRUS PRODUCED BY TRANSFECTED HEP G2 CELLS CAUSES HEPATITIS IN CHIMPANZEES [J].
ACS, G ;
SELLS, MA ;
PURCELL, RH ;
PRICE, P ;
ENGLE, R ;
SHAPIRO, M ;
POPPER, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (13) :4641-4644
[3]  
BEASLEY RP, 1982, HEPATOLOGY S, V2, pS1
[4]  
CHENG G, 1999, CHIN J MED LAB SCI, V22, P135
[5]   Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant Baculovirus [J].
Delaney, WE ;
Isom, HC .
HEPATOLOGY, 1998, 28 (04) :1134-1146
[6]   Major differences between WHV and HBV in the regulation of transcription [J].
Di, Q ;
Summers, J ;
Burch, JB ;
Mason, WS .
VIROLOGY, 1997, 229 (01) :25-35
[7]   HEPATITIS-B VIRUS-INFECTION AND PRIMARY HEPATOCELLULAR-CARCINOMA [J].
FEITELSON, M .
CLINICAL MICROBIOLOGY REVIEWS, 1992, 5 (03) :275-301
[8]   Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro [J].
Gong, ZJ ;
De Meyer, S ;
Clarysse, C ;
Verslype, C ;
Neyts, J ;
De Clercq, E ;
Yap, SH .
JOURNAL OF VIRAL HEPATITIS, 1999, 6 (03) :229-236
[9]  
Hagelstein J, 1998, ARZNEIMITTEL-FORSCH, V48, P343
[10]   Antiviral activities of extracts isolated from Terminalis chebula Retz., Sanguisorba officinalis L., Rubus coreanus Miq. and Rheum palmatum L. against hepatitis B virus [J].
Kim, TG ;
Kang, SY ;
Jung, KK ;
Kang, JH ;
Lee, E ;
Han, HM ;
Kim, SH .
PHYTOTHERAPY RESEARCH, 2001, 15 (08) :718-720